Banked Cord Blood Stem Cells
Cerebral Palsy
Key Facts
About Cryo-Cell
Cryo-Cell's mission is to provide families with secure, high-quality preservation of newborn stem cells for potential future therapeutic use. The company's core achievement is establishing itself as a leader in the private cord blood banking industry, serving nearly half a million parents globally since its founding in 1989 and maintaining a strong transplant record. Its strategy centers on leveraging its proprietary PrepaCyte-CB processing technology to offer a superior cell product, while exploring the expansion of its service model through research into new clinical applications for banked cells. The company aims to transition from a pure storage service to a more integrated player in the regenerative medicine ecosystem.
View full company profileAbout Cryo-Cell
Cryo-Cell's mission is to provide families with secure, high-quality preservation of newborn stem cells for potential future therapeutic use. The company's core achievement is establishing itself as a leader in the private cord blood banking industry, serving nearly half a million parents globally since its founding in 1989 and maintaining a strong transplant record. Its strategy centers on leveraging its proprietary PrepaCyte-CB processing technology to offer a superior cell product, while exploring the expansion of its service model through research into new clinical applications for banked cells. The company aims to transition from a pure storage service to a more integrated player in the regenerative medicine ecosystem.
View full company profileAbout Cryo-Cell
Cryo-Cell's mission is to provide families with secure, high-quality preservation of newborn stem cells for potential future therapeutic use. The company's core achievement is establishing itself as a leader in the private cord blood banking industry, serving nearly half a million parents globally since its founding in 1989 and maintaining a strong transplant record. Its strategy centers on leveraging its proprietary PrepaCyte-CB processing technology to offer a superior cell product, while exploring the expansion of its service model through research into new clinical applications for banked cells. The company aims to transition from a pure storage service to a more integrated player in the regenerative medicine ecosystem.
View full company profileAbout Cryo-Cell
Cryo-Cell's mission is to provide families with secure, high-quality preservation of newborn stem cells for potential future therapeutic use. The company's core achievement is establishing itself as a leader in the private cord blood banking industry, serving nearly half a million parents globally since its founding in 1989 and maintaining a strong transplant record. Its strategy centers on leveraging its proprietary PrepaCyte-CB processing technology to offer a superior cell product, while exploring the expansion of its service model through research into new clinical applications for banked cells. The company aims to transition from a pure storage service to a more integrated player in the regenerative medicine ecosystem.
View full company profileTherapeutic Areas
Other Cerebral Palsy Drugs
| Drug | Company | Phase |
|---|---|---|
| Cerebral Palsy Program | StemCyte | Clinical Trial |
| SCiP™ | SpineX | Pivotal Trial Planned |